Sectors

Stripe invested in the tax management software developer through a series C round which reportedly almost tripled its valuation to $700m.

Susquehanna International Group and Globe Telecom returned to reinvest in the livestream platform developer through a $73.6m round.

Novartis Venture Fund and Hikma Ventures are set to exit the online medical treatment provider in a cash-and-stock purchase by 23andme.

The digital therapeutics developer closed a series B round that included corporate venturing units and existing investors Hikma Ventures and Sanofi Ventures.

Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the immunotherapy developer.

Online insurance provider Justos raised $35.8m in a SoftBank-led series A round while social game studio GreenPark Sports closed a $31m series B that included Alameda Research.

The Coinbase, Binance, SoftBank and Circle-backed crypto exchange operator has hauled in funding at a valuation of $25bn.

The RTL and Mediaocean-backed advertising technology provider increased its valuation to $1.4bn in a round which will help it increase staff numbers.

The online investment platform developer tripled its valuation to $3bn in a round that included Propel Venture Partners.

Takeda, Merck & Co, Ipsen and Merck Group all scored exits as the immuno-oncology drug developer floated at the bottom of its IPO range.

Blue Venture Fund and CVS Health Ventures helped the telemedicine system developer raise funding which will boost its expansion into new markets and expand its treatment offering.